Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 0 | |
Outperform | 1 | |
Hold | 2 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 3 analysts offering 12 month price targets for Fulgent Genetics Inc have a median target of 27.00, with a high estimate of 30.00 and a low estimate of 22.00. The median estimate represents a 59.29% increase from the last price of 16.95.
High | 77.0% | 30.00 |
Med | 59.3% | 27.00 |
Low | 29.8% | 22.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 26, 2025.
Average growth rate | +106.67% |
Average growth rate | +1,568.27% |
More ▼
Revenue history & estimates in USD
Average growth rate | -3.53% |
Average growth rate | +310.23% |
More ▼